NEW
YORK, July 26, 2024 /PRNewswire/ -- TMRW Life
Sciences (TMRW), a fertility technology company setting a new
standard of care in fertility storage, today announced that it is
providing free cryostorage for frozen sperm, eggs and embryos for
all members of the 2024 US Olympic and Paralympic Teams who wish to
move their precious cells to TMRW's state-of-the-art
biorepository.
Many people feel they must choose between career excellence and
building their families, leading some to take advantage of
fertility preservation options such as sperm, egg and/or embryo
banking. With this offer, TMRW hopes to relieve the world's best
athletes of one of the fertility preservation financial burdens, so
that they can focus on their performance while knowing their
specimens are safely stored.
TMRW Biorepository is the only offsite storage provider in
the United States with a fully
integrated digital specimen management and storage platform. With a
digital chain of custody, around-the-clock human and digital
monitoring, HIPAA compliance, ISO certifications and military-grade
data security, TMRW helps reduce the risk of specimen errors,
mix–up, damage and loss compared to traditional manual systems used
at most fertility clinics and other biorepositories. Those athletes
who store their specimens with the TMRW Biorepository will receive
the highest standard of care available today in offsite fertility
cryostorage in the United
States.
"As a company at the forefront of reproductive technology, we
are proud to extend our services to the extraordinary members of
the 2024 US Olympic and Paralympic teams. Providing free,
state-of-the-art embryo, egg and sperm cryostorage is our tribute
to their exceptional talent and commitment," said Louis Villalba, TMRW's Chief Executive Officer.
"We hope this gesture allows them to focus on their athletic goals,
knowing their family building options are safely stored for future
use."
"With this offer, we aim to honor our athletes' achievements and
support their future aspirations, both on and off the field," said
Lindsay Beck, TMRW's Chief Impact
Officer. "This is our way of saying thank you for inspiring the
world with your excellence."
Athletes can start the online process here.
TMRW is not affiliated, associated, authorized, endorsed
by, or in any way officially connected with the U.S. Olympic team,
the International Olympic Committee or any of its
affiliates.
About TMRW Life Sciences
Founded in 2018, TMRW Life Sciences, Inc., is a fertility
technology automating the IVF lab starting with the world's first
automated platforms for the safe management and storage of frozen
sperm, eggs and embryos. For the first time, frozen specimens can
be digitally identified and tracked, safely managed with automated
robotics, and remotely monitored around the clock. TMRW's
next-generation technology platforms set a new standard of care,
reducing potential points of failure by 94% compared to manual
systems. TMRW delivers peace of mind by helping reduce the risk of
specimen mix-up, damage, or loss. Named Fast Company's #1 Most
Innovative Biotech company in 2022, TMRW has been adopted by
leading clinics across the United States and is just
entering the market in the United
Kingdom and Europe. For more information, visit
tmrwlifesciences.com.
View original
content:https://www.prnewswire.com/news-releases/tmrw-life-sciences-offers-2024-united-states-summer-olympic--paralympic-teams-free-cryostorage-for-frozen-embryos-eggs--sperm-at-state-of-the-art-biorepository-302207474.html
SOURCE TMRW Life Sciences